mifepristone has been researched along with Ovarian Hyperstimulation Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, J; Qi, Q; Wang, Y; Xia, Y; Xie, Q | 1 |
| Chen, Y; Luo, J; Qi, Q; Wang, Y; Xie, Q | 1 |
| Freundl, G; Gnoth, C; Halbe, E | 1 |
| Ishikawa, K; Ohba, T; Okamura, H; Tanaka, N; Ujioka, T | 1 |
| Iqbal, M; Ishikawa, K; Ohba, T; Okamura, H; Okamura, Y; Tanaka, N | 1 |
| Kawano, T; Matsuura, K; Okamura, H; Ujioka, T | 1 |
| Matsuura, K; Okamura, H; Tanaka, N; Ujioka, T | 1 |
1 trial(s) available for mifepristone and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: a prospective randomized trial.
Topics: Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Letrozole; Mifepristone; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Prospective Studies | 2023 |
6 other study(ies) available for mifepristone and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Effect of GnRH-antagonist, mifepristone and letrozole on preventing ovarian hyperstimulation syndrome in rat model.
Topics: Animals; Aromatase Inhibitors; Caspase 3; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Gonadotropin-Releasing Hormone; Interleukin-6; Letrozole; Mifepristone; Ovarian Hyperstimulation Syndrome; Ovary; Progesterone; Random Allocation; Rats, Wistar; Vascular Endothelial Growth Factor A | 2021 |
Persistent ascites after ovarian hyperstimulation syndrome and administration of mifepristone (RU 486) for the termination of pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Ascites; Female; Fertilization in Vitro; Humans; Mifepristone; Ovarian Hyperstimulation Syndrome; Pregnancy; Sperm Injections, Intracytoplasmic; Ultrasonography | 2003 |
Ovarian hyperstimulation syndrome-model rats; the manifestation and clinical implication.
Topics: Animals; Chorionic Gonadotropin; Disease Models, Animal; Female; Humans; Kallikrein-Kinin System; Mifepristone; Ovarian Hyperstimulation Syndrome; Progesterone; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A | 2003 |
Organ-specific production control of vascular endothelial growth factor in ovarian hyperstimulation syndrome-model rats.
Topics: Animals; Animals, Newborn; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gene Expression; Hormone Antagonists; Horses; Humans; Mifepristone; Organ Size; Ovarian Hyperstimulation Syndrome; Ovary; Progesterone; Rats; Rats, Wistar; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A | 2003 |
Role of progesterone in capillary permeability in hyperstimulated rats.
Topics: Adrenocorticotropic Hormone; Animals; Capillary Permeability; Chorionic Gonadotropin; Disease Models, Animal; Estradiol; Female; Gonadotropins, Equine; Hormone Antagonists; Humans; Mifepristone; Ovarian Hyperstimulation Syndrome; Progesterone; Rats; Rats, Wistar | 1997 |
Involvement of ovarian kinin-kallikrein system in the pathophysiology of ovarian hyperstimulation syndrome: studies in a rat model.
Topics: Animals; Bradykinin; Bradykinin Receptor Antagonists; Capillary Permeability; Chorionic Gonadotropin; Disease Models, Animal; Estradiol; Evans Blue; Female; Hormone Antagonists; Kallikreins; Kinins; Mifepristone; Ovarian Hyperstimulation Syndrome; Ovary; Peritoneum; Progesterone; Protease Inhibitors; Rats; Rats, Wistar | 1998 |